Cleveland Clinic

Historic Opportunity to End Breast Cancer Launched Today

Retrieved on: 
Tuesday, January 30, 2024
Hope, Woman, Patient, Monroe Dunaway Anderson, Research, NBC News, Roswell Park, Cancer, Science, Friends, Survivor, Breast cancer, University, Vaccination, Immunotherapy, Recurrence, News, Dana–Farber Cancer Institute, Cleveland Clinic, Government, Vaccine, Immune system

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Today two high-profile breast cancer survivors, with the nation's top breast cancer doctors backing them, launched the Pink Eraser Project that will accelerate development of life saving breast cancer vaccines, aiming to shorten the process by 25 years.

Key Points: 
  • NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Today two high-profile breast cancer survivors, with the nation's top breast cancer doctors backing them, launched the Pink Eraser Project that will accelerate development of life saving breast cancer vaccines, aiming to shorten the process by 25 years.
  • "The science to end breast cancer exists by harnessing the power of our own immune systems.
  • Dahlgren and Young, both breast cancer survivors, met when Dahlgren interviewed Young about her breast cancer journey and her quest to save women from the devastating disease effects.
  • "We are at a unique moment in time when the right collaboration and funding could mean breast cancer vaccines within a decade.

PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer

Retrieved on: 
Monday, January 22, 2024
Senior, PDS, Employment, Cleveland Clinic, Hematology, Case Western Reserve University, University, Cancer, Boehringer Ingelheim, Infection, Cornell University, Baxter International, Retirement, Vaccine, Biotechnology, PDSB, Oncology

Dr. Shepard succeeds Lauren V. Wood, M.D., who is retiring from the Company after five years in the role.

Key Points: 
  • Dr. Shepard succeeds Lauren V. Wood, M.D., who is retiring from the Company after five years in the role.
  • Dr. Wood will continue to be available to PDS Biotech during a handover period to facilitate the transition of the role to Dr. Shepard.
  • “We are pleased to welcome Kirk to the PDS Biotech team.
  • Prior to joining PDS Biotech, Dr. Shepard was Chief Medical Officer, Senior Vice President and Head of the Global Medical Affairs Oncology Business Group at Eisai Pharmaceutical Company.

Dr. Ferrer BioPharma Awarded Winner at CPHI Pharmapack 2024 for Groundbreaking GentleMist Technology

Retrieved on: 
Thursday, January 25, 2024
Biotechnology, Medical Devices, Other Health, Health, Pharmaceutical, Broward County, Florida, Cleveland Clinic, Small business, South Dakota State University, Absorption, Pharmaceutical industry

The company’s groundbreaking GentleMist Technology received the " Patient-Centric Design " award, highlighting its revolutionary approach in intranasal drug delivery.

Key Points: 
  • The company’s groundbreaking GentleMist Technology received the " Patient-Centric Design " award, highlighting its revolutionary approach in intranasal drug delivery.
  • The GentleMist Technology represents a paradigm shift in the administration of medications as a cutting-edge intranasal drug delivery device that revolutionizes how medications are administered.
  • Moving beyond the limitations of traditional nozzles, which causes discomfort, GentleMist Technology utilizes advanced fluid dynamics principles to create a gentler and more effective nasal spray.
  • Dr. Ferrer BioPharma holds multiple patents for medications and devices, distinguishing themselves by utilizing their proprietary GentleMist Technology in all their nasal and throat sprays.

New National Survey by Desai Sethi Urology Institute Reveals Impact of Technology & Multidisciplinary Collaboration on the Future of Urology

Retrieved on: 
Monday, January 22, 2024
Artificial intelligence, Patient, Research, Report, Health, Global health, Field, University, AI, Medicine, Radiology, UCLA, Biomedical engineering, Cleveland Clinic, Machine learning, Fox Chase Cancer Center, YouGov, Education, General practitioner, Nursing

MIAMI, Jan. 22, 2024 /PRNewswire/ -- The Desai Sethi Institute of Urology (DSUI) at the University of Miami Miller School of Medicine unveiled the findings of its inaugural State of Urology survey and report today, which provides insights into the current landscape of urology and outlines implications for the future direction of the specialty. The report captures the perspectives of urologists and the general public on critical issues and emerging trends in urology.

Key Points: 
  • The report captures the perspectives of urologists and the general public on critical issues and emerging trends in urology.
  • The survey reveals a strong consensus among urologists on the importance of cross-disciplinary collaboration.
  • Nearly half (47%) of urologists identified the development of new technologies as the most impactful trend in the coming years.
  • For more information about the DSUI State of Urology Survey & Report, visit med.miami.edu/plp/dsui .

Meijer Opens Fairfax Market in Cleveland Innovation District

Retrieved on: 
Tuesday, January 16, 2024
Honey, WIC, African Americans, Food, Health, City, Golden Joystick Awards, Salad, Ward, Work, DoorDash, Spice, Coffee, SNAP, Wine, Hoisin sauce, Cleveland Clinic, Organization, Market, Food security, Karamu House, Growth

GRAND RAPIDS, Mich., Jan. 16, 2024 /PRNewswire/ -- Meijer opened Fairfax Market in Cleveland today, bringing a mix of fresh, local and convenient food at low prices to customers in Cleveland's Fairfax neighborhood.

Key Points: 
  • GRAND RAPIDS, Mich., Jan. 16, 2024 /PRNewswire/ -- Meijer opened Fairfax Market in Cleveland today, bringing a mix of fresh, local and convenient food at low prices to customers in Cleveland's Fairfax neighborhood.
  • Fairfax Market is the retailer's fifth neighborhood market, and the first outside of Michigan.
  • The store is part of a broader revitalization project designed to bolster economic activity, add jobs and bring nutritious, affordable food to the Cleveland Innovation District.
  • We've spent the last year connecting with local vendors and asking neighbors what they'd like to see in the market," Fairfax Market Store Director Alan Jordan said.

CurePSP Funds Collaborative Projects Focused on Care of Neurodegenerative Diseases

Retrieved on: 
Tuesday, January 9, 2024
Patient, Research, ALS, Multiple system atrophy, Vanderbilt University, Baylor College of Medicine, University, MSA, Parkinson's disease, Life expectancy, Education, Corticobasal degeneration, CBD, PSP, Practitioner, Cleveland Clinic, Clinical trial, Diagnosis, Prevalence, Nursing

CARES promotes multi-center research within the CurePSP Centers of Care, a network of 33 medical institutions with the mission to enhance the diagnosis and treatment of PSP, CBD and MSA.

Key Points: 
  • CARES promotes multi-center research within the CurePSP Centers of Care, a network of 33 medical institutions with the mission to enhance the diagnosis and treatment of PSP, CBD and MSA.
  • These neurodegenerative diseases share symptoms with Parkinson's disease, yet have a prevalence and life expectancy similar to amyotrophic lateral sclerosis (ALS).
  • Projects involve at least two Centers of Care and focus on the evaluation of person-centered care, access for underserved populations, or education of the medical community.
  • Cleveland Clinic of Ohio and Las Vegas will conduct a pilot training course on rare Parkinsonian diseases geared towards nurse practitioners and physician assistants.

Homecare Hub & Penguin Living open Hamilton Residential Assisted Living Homes - Plan for up 200 beds over the next year in Response to Long-Term Care Crisis

Retrieved on: 
Monday, January 8, 2024
Penguin, IBM, Cleveland Clinic, Family, Partnership, Toronto-Dominion Bank, Friends, Internal medicine, Nursing, Long-term care, Disability, Pressure, Housing, University, Ageing, Assisted living, Trillium Health Partners, Bed

HAMILTON, ON, Jan. 8, 2024 /PRNewswire/ - Homecare Hub and Penguin Living proudly announce the opening of their newest assisted living residences in Hamilton, Ontario.

Key Points: 
  • HAMILTON, ON, Jan. 8, 2024 /PRNewswire/ - Homecare Hub and Penguin Living proudly announce the opening of their newest assisted living residences in Hamilton, Ontario.
  • The opening of their 3 houses in Warren Park last month marked the first set of many small-scale residential assisted living homes that will be created in Hamilton.
  • Their first 30 beds are available now, with an on-demand system that allows for the system to scale up.
  • For more information about the new Assisted Living communities being built, or Homecare Hub and its innovative senior housing and home care solutions, please visit www.homecarehub.ca/shared-living or call Homecare Hub at 1-888-227-3080.

World’s First Patients Treated With Novel Edison® Histotripsy System

Retrieved on: 
Friday, January 5, 2024
Medical Devices, Surgery, Hospitals, Clinical Trials, Health Technology, Biotechnology, University, Health, Education, Oncology, Liver, Metastasis, Cleveland Clinic, Science, Liver tumor, Division, Multimedia, Physician, FDA, Pain, Disease, MD, Doctor of Philosophy, Thomas Edison, Kidney, Patient, Medical imaging

In the same week Cleveland Clinic treated their initial patients suffering from liver tumors utilizing histotripsy.

Key Points: 
  • In the same week Cleveland Clinic treated their initial patients suffering from liver tumors utilizing histotripsy.
  • HistoSonics' image guided sonic beam therapy system uses proprietary technology and advanced imaging to deliver non-invasive, personalized treatments with precision and control.
  • The science of histotripsy uses focused sound energy to produce controlled acoustic cavitation that mechanically destroys and liquifies targeted tissue at sub-cellular levels.
  • By destroying targeted liver tumors, histotripsy opens the opportunities for patients to be downstaged and bridged for surgical resections and transplantation,” said Dr. Hernandez-Alejandro.

Global Steerable Needles (Bevel-tip Flexible, Symmetric-tip) Market Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 5, 2024
Medical Devices, Health, Cleveland Clinic, EPFL, NCBI, Biopsy, Government, Brushed DC electric motor, Needle, Hospital, Cancer, DSM-IV codes, USD, Molecular Modeling Database, Growth, ARC, RAS, Cardiovascular disease, Medical device

The "Steerable Needles Market Size, Share & Trends Analysis Report By Type (Bevel-tip Flexible, Symmetric-tip), By Application (Biopsy, Tumor Ablation, Robotic Assisted Surgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Steerable Needles Market Size, Share & Trends Analysis Report By Type (Bevel-tip Flexible, Symmetric-tip), By Application (Biopsy, Tumor Ablation, Robotic Assisted Surgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Thus, an increasing number of robotic-assisted surgery (RAS) cases are anticipated to boost demand for steerable needles during the forecast period.
  • These advancements have led to the development of more precise and accurate steerable needles and steerable needles that are compatible with a wide range of imaging modalities.
  • This initiative will strengthen the adoption of newly launched steerable needles worldwide, thereby driving the market growth.

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

Retrieved on: 
Wednesday, January 3, 2024
Category 1, Conference, Cleveland Clinic, Hospital, Sale, Johns Hopkins Hospital, Cone Health Women's Hospital, Prostate cancer, Level 1, Monroe Dunaway Anderson, Investment, TSX, News, Prostate, Pharmaceutical industry

Profound anticipates total revenues for the fourth quarter of 2023 to be in the approximate range of $1.9 million to $2.0 million, with the full amount coming from recurring revenue, which consists of the sale of TULSA-PRO® consumables, lease of medical devices, procedures and services associated with extended warranties.

Key Points: 
  • Profound anticipates total revenues for the fourth quarter of 2023 to be in the approximate range of $1.9 million to $2.0 million, with the full amount coming from recurring revenue, which consists of the sale of TULSA-PRO® consumables, lease of medical devices, procedures and services associated with extended warranties.
  • This represents recurring revenue growth of between 51% and 59% year-over-year, and between 10% and 16% sequentially over the 2023 third quarter.
  • For the full year 2023, Profound anticipates total revenues to be in the approximate range of $7.1 million to $7.2 million.
  • These figures are preliminary and unaudited, and actual revenues may differ.